儿童肺炎支原体肺炎诊治专家共识（2015年版）

Expert consensus on diagnosis and treatment of mycoplasma pneumoniae pneumonia in children （ 2015 ）

肺炎支原体肺炎（MPP）占儿童社区获得性肺炎的10％～40％，是儿科医师广泛关注的临床问题。近年来，儿童MPP呈现不少新的特点，其诊断和治疗问题需要规范。为此，中华医学会儿科学分会呼吸学组和《中华实用儿科临床杂志》编辑委员会制定了《儿童肺炎支原体肺炎诊治专家共识》。共识简要介绍了肺炎支原体（MP）病原学、MP感染的发病机制和流行病学，重点介绍了儿童MPP的临床表现、影像学改变和实验室诊断，介绍了抗菌药物、糖皮质激素、丙种球蛋白等药物在儿童MPP中的治疗作用和方案。

Mycoplasnka pneumoniae pneumonia （MPP） is one of the commonest causes of pediatric community - acquired pneumonia,causing 10% -40% of cases. MPP has aroused widespread concern among pediatricians. In recent years,many new characteristics of pediatric MPP have been presented. So,the standardization of the diagnosis and treatment of pediatric MPP is also required. For this purpose, respiratory branch of Chinese pediatric society of Chinese medical association and editorial board of Chinese journal of applied clinical pediatrics formulated the ＂Expert consensus on the diagnosis and treatment of mycoplasma pneumoniae pneumonia in children＂. This consensus briefly intro- duces etiology, pathogenesis and epidemiology of pediatric MPP;and focuses on the clinical manifestation,pulmonary radiograph,laboratory diagnostics ; and recommended antimicrobial dtaags, systemic glucocortieoid steroids, intravenous immunoglobulin and other medications for MPP in children.